Nothing Special   »   [go: up one dir, main page]

YU34876B - Process for obtaining novel n-substituted pyrrolidines - Google Patents

Process for obtaining novel n-substituted pyrrolidines

Info

Publication number
YU34876B
YU34876B YU306/71A YU30671A YU34876B YU 34876 B YU34876 B YU 34876B YU 306/71 A YU306/71 A YU 306/71A YU 30671 A YU30671 A YU 30671A YU 34876 B YU34876 B YU 34876B
Authority
YU
Yugoslavia
Prior art keywords
obtaining novel
substituted pyrrolidines
pyrrolidines
substituted
novel
Prior art date
Application number
YU306/71A
Other languages
English (en)
Other versions
YU30671A (en
Inventor
Lucien Honore Joseph
Honore Joseph Lucien
Raymond Dilbeek
Dilbeek Raymond
Original Assignee
Ucb Union Chimique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Union Chimique filed Critical Ucb Union Chimique
Publication of YU30671A publication Critical patent/YU30671A/xx
Publication of YU34876B publication Critical patent/YU34876B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
YU306/71A 1970-02-13 1971-02-10 Process for obtaining novel n-substituted pyrrolidines YU34876B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB697870A GB1309692A (en) 1970-02-13 1970-02-13 N-substituted lactams

Publications (2)

Publication Number Publication Date
YU30671A YU30671A (en) 1979-10-31
YU34876B true YU34876B (en) 1980-04-30

Family

ID=9824325

Family Applications (2)

Application Number Title Priority Date Filing Date
YU306/71A YU34876B (en) 1970-02-13 1971-02-10 Process for obtaining novel n-substituted pyrrolidines
YU01445/78A YU144578A (en) 1970-02-13 1978-06-19 Process for obtaining new n-substituted pyrrolidones

Family Applications After (1)

Application Number Title Priority Date Filing Date
YU01445/78A YU144578A (en) 1970-02-13 1978-06-19 Process for obtaining new n-substituted pyrrolidones

Country Status (15)

Country Link
JP (2) JPS535301B1 (cs)
BE (1) BE762728R (cs)
CH (1) CH530395A (cs)
CS (2) CS167911B2 (cs)
DE (1) DE2106418C2 (cs)
DK (1) DK137451B (cs)
ES (1) ES388135A2 (cs)
FI (1) FI54916C (cs)
FR (1) FR2081508B2 (cs)
GB (1) GB1309692A (cs)
MY (1) MY7400072A (cs)
NL (1) NL168830C (cs)
SU (2) SU508185A3 (cs)
YU (2) YU34876B (cs)
ZA (1) ZA71877B (cs)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1045043B (it) * 1975-08-13 1980-04-21 Isf Spa Derivati pirrolidinici
GB1583871A (en) * 1976-10-19 1981-02-04 Ucb Sa Anti-aggregants
BE864269A (fr) * 1977-03-03 1978-06-16 Parke Davis & Co Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire
ATE27T1 (de) 1978-05-08 1981-04-15 Ucb Sa Lactam-n-essigsaeuren und ihre amide, verfahren zu ihrer herstellung und heilmittel, die sie enthalten
IT1141287B (it) * 1979-06-13 1986-10-01 Nattermann A & Cie Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono
FR2515179A1 (fr) * 1981-07-24 1983-04-29 Hoffmann La Roche Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique
EP0089900B1 (en) * 1982-03-24 1985-12-27 Prodes S.A. New n-((2-oxo-1-pyrrolidinyl)acetyl)piperazines, the methods of producing such new compounds and their salts as well as pharmaceutical preparations for therapeutic use containing these compounds or salts
GB8412357D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
GB8412358D0 (en) * 1984-05-15 1984-06-20 Ucb Sa Pharmaceutical composition
DE3420193A1 (de) * 1984-05-30 1985-12-05 Boehringer Ingelheim KG, 6507 Ingelheim Neue substituierte pyrrolidinone, verfahren zu ihrer herstellung und arzneimittel
US4804400A (en) * 1986-09-12 1989-02-14 Ciba-Geigy Corporation N-phenyl-maleimides and herbicidal and plant growth regulating methods of use thereof
GB8827389D0 (en) * 1988-11-23 1988-12-29 Ucb Sa Process for preparation of(s)alpha-ethyl-2-oxo-1-pyrrolidineacetamide
AR020115A1 (es) * 1998-08-06 2002-04-10 Daiichi Seiyaku Co Agente terapeutico o preventivo para epilepsias rebeldes y uso del compuesto para la produccion de los mismos
GB0004297D0 (en) * 2000-02-23 2000-04-12 Ucb Sa 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses
US6686477B2 (en) 2000-09-29 2004-02-03 Eastman Chemical Company Highly enantiomerically pure lactam-substituted propanoic acid derivatives and methods of making and using same
EP1395560A1 (en) 2001-05-23 2004-03-10 Ucb, S.A. 2-oxo-piperidinyl- and 2-oxo-azepanyl alkanoic acid derivativ es for the treatment of epilepsy and other neurological disorders
US7122682B2 (en) * 2001-08-10 2006-10-17 Ucb, S.A. Oxopyrrolidine compounds, preparation of said compounds and their use in the manufacturing of levetiracetam and analogues
ES2281545T3 (es) * 2001-10-08 2007-10-01 Ucb, S.A. Uso de derivados de 2-oxo-1-pirrolidina para la preparacion de un farmaco para tratar la discinesia.
CA2515090A1 (en) 2003-02-03 2004-08-19 Teva Pharmaceutical Industries Ltd Process for producing levetiracetam
ES2214147B1 (es) * 2003-02-28 2005-10-01 Farma-Lepori S.A. Procedimiento de obtencion de un agente antiepileptico.
US7531673B2 (en) 2004-02-18 2009-05-12 Dr. Reddy's Laboratories Limited Preparation of amino acid amides
CA2488325C (en) 2004-11-22 2010-08-24 Apotex Pharmachem Inc. Improved process for the preparation of (s)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide and (r)-alpha-ethyl-2-oxo-1-pyrrolidineacetamide
WO2006095362A1 (en) * 2005-03-10 2006-09-14 Rubamin Limited Process for preparing levetiracetam
ES2441178T3 (es) 2005-06-01 2014-02-03 Ucb Pharma, S.A. Derivados de 2-oxo-1-pirrolidina, procedimientos para prepararlos y el uso terapéutico de los mismos sobre el sistema nervioso central
EP2147911A1 (en) 2008-07-24 2010-01-27 ZaCh System S.p.A. Process for the preparation of levetiracetam
US20100099735A1 (en) 2008-10-16 2010-04-22 Michela Gallagher Methods and compositions for improving cognitive function
WO2010132693A2 (en) 2009-05-13 2010-11-18 Nektar Therapeutics Oligomer-containing pyrrolidine compounds
US7939676B2 (en) 2009-09-17 2011-05-10 Zach System S.P.A. Process for the preparation of levetiracetam
US20110212928A1 (en) 2010-02-09 2011-09-01 The Johns Hopkins University Methods and compositions for improving cognitive function
EP3610890A1 (en) 2012-11-14 2020-02-19 The Johns Hopkins University Methods and compositions for treating schizophrenia
ES2881081T3 (es) 2013-03-15 2021-11-26 Agenebio Inc Procedimientos y composiciones para mejorar la función cognitiva
EP2968237A4 (en) 2013-03-15 2016-08-31 Univ Johns Hopkins METHOD AND COMPOSITIONS FOR IMPROVING COGNITIVE FUNCTION
HUE053734T2 (hu) 2014-01-21 2021-07-28 Janssen Pharmaceutica Nv 2-es altípusú metabotróp glutamáterg receptor pozitív allosztérikus modulátorait tartalmazó kombinációk és alkalmazásuk
RS61334B1 (sr) 2014-01-21 2021-02-26 Janssen Pharmaceutica Nv Kombinacije koje obuhvataju pozitivne alosterične modulatore metabotropnog glutamatergičnog receptora podtipa 2 i njihova upotreba
CN104059010A (zh) * 2014-06-12 2014-09-24 浙江华海药业股份有限公司 一种制备2-(2-氧代吡咯烷-1-基)-丁酸酯的方法
CN106591179B (zh) * 2016-12-05 2018-07-03 长兴制药股份有限公司 甲基包囊菌及其在选择性拆分制备(S)-α-乙基-2-氧-1-吡咯烷乙酸盐上的应用
RU2663899C1 (ru) * 2017-07-19 2018-08-13 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" Способ получения 1-карбамоилметил-4-фенил-2-пирролидона
US11384050B1 (en) 2021-02-03 2022-07-12 Vitaworks Ip, Llc Method for preparing levetiracetam and intermediates thereof
WO2024039886A1 (en) 2022-08-19 2024-02-22 Agenebio, Inc. Benzazepine derivatives, compositions, and methods for treating cognitive impairment

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams

Also Published As

Publication number Publication date
NL7101697A (cs) 1971-08-17
FI54916C (fi) 1979-04-10
DE2106418A1 (de) 1971-08-19
DK137451B (da) 1978-03-06
CS167912B2 (cs) 1976-05-28
NL168830B (nl) 1981-12-16
SU508186A3 (ru) 1976-03-25
FI54916B (fi) 1978-12-29
ES388135A2 (es) 1973-05-01
JPS5420491B2 (cs) 1979-07-23
ZA71877B (en) 1971-10-27
MY7400072A (en) 1974-12-31
JPS535301B1 (cs) 1978-02-25
NL168830C (nl) 1982-05-17
BE762728R (fr) 1971-08-10
YU30671A (en) 1979-10-31
FR2081508A2 (cs) 1971-12-03
JPS53130656A (en) 1978-11-14
DK137451C (cs) 1978-07-24
SU508185A3 (ru) 1976-03-25
GB1309692A (en) 1973-03-14
FR2081508B2 (cs) 1975-06-06
CH530395A (fr) 1972-11-15
CS167911B2 (cs) 1976-05-28
YU144578A (en) 1982-10-31
DE2106418C2 (de) 1983-12-22

Similar Documents

Publication Publication Date Title
YU34876B (en) Process for obtaining novel n-substituted pyrrolidines
YU191271A (en) Process for obtaining novel substituted phenyl-pyrrolidones
JPS5436230A (en) Process for preparing substituted halophenylacetic amide
YU258071A (en) Process for preparing diesteramides
YU59771A (en) Process for preparing novel amido compounds
EG10628A (en) Process for making 7-halolincomycin
ZA714007B (en) Lactam process
YU302271A (en) Process for obtaining benzobicycloalkane amines
YU250078A (en) Process for preparing phenylaminoalkanes
YU188374A (en) Process for obtaining n-substituted p-amino-3-nitro-benzophenones
ZA711022B (en) Process for preparing novel substituted quinoxaline-di-oxides
JPS53116397A (en) Process for preparing imidazoleeribocyclophosphate
IL36143A0 (en) Process for preparing n-alkyl-dimethylamines
YU34682B (en) Process for preparing novel quinazolone-diurethanes
YU37160B (en) Process for obtaining n-substituted cycloserines
YU34139B (en) Process for preparing 9alfa-chloro-11beta-hydroxy-3-keto-delta-4-pregnenes
YU268371A (en) Process for preparing delta-substituted 2-aminomethylbenzylalcohols
YU25671A (en) Process for preparing des-phenylalanine-bi-insulin
YU34114B (en) Process for preparing n-substituted acetaldimines
CS194182B2 (en) Process for preparing n-substituted beta-amino-alpha benylacrylonitriles
YU34672B (en) Process for preparing 1-ethyl-2-amino-methyl pyrrolidine
RO72550B (ro) Procedeu de preparare a unor tiolcarbamati
YU35351B (en) Process for preparing novel substituted phenyl-thiolcarbamates
YU195871A (en) Process for preparing thiadiazolyl-carbamides
CS194152B2 (en) Process for preparing n-substituted beta-amino-alpha-benzylacrylonitriles